Search

Your search keyword '"Pernod, Gilles"' showing total 224 results

Search Constraints

Start Over You searched for: Author "Pernod, Gilles" Remove constraint Author: "Pernod, Gilles"
224 results on '"Pernod, Gilles"'

Search Results

201. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial.

202. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.

203. Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis.

204. Endovascular Treatment of Post-thrombotic Venous Ilio-Femoral Occlusions: Prognostic Value of Venous Lesions Caudal to the Common Femoral Vein.

205. Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

206. Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

207. Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

208. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

209. Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study.

210. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

211. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism: comment.

212. Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluation.

213. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

214. Critical limb ischaemia and the response to bone marrow-derived cell therapy according to tcPO 2 measurement.

215. [Etiologic assessment of venous thromboembolism].

216. [Perioperative management of new oral anticoagulants].

217. Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trial.

218. [Management of major bleeding complications in patients on long-term treatment with oral anticoagulants].

219. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

220. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

221. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].

222. [When to test for thrombophilia?].

223. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.

224. Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis.

Catalog

Books, media, physical & digital resources